A GC test is a laboratory test for gonorrhea, one of the most common sexually transmitted infections in the United States. “GC” is shorthand for gonococcus, the type of bacteria (Neisseria gonorrhoeae) that causes the infection. You’ll often see it written on lab orders, insurance statements, or test results as “GC test,” “GC/CT test,” or “NAAT for GC.” If you spotted this abbreviation and weren’t sure what it meant, the short answer is: it’s a gonorrhea screening test, and it’s one of the most routine STI tests performed today.
How the Test Works
Most GC tests today use a method called nucleic acid amplification testing, or NAAT. Instead of trying to grow the bacteria in a lab dish (the old approach), NAAT detects the genetic material of the gonorrhea bacterium directly from your sample. This is a significant upgrade over older culture-based testing, which required the bacteria to be alive during transport and could take several days to produce results. NAAT can detect as little as a single copy of the bacterium’s DNA, making it far more sensitive and reliable.
The CDC considers NAAT the preferred method for diagnosing both gonorrhea and chlamydia. Culture testing is still used in certain situations, particularly when providers need to check which antibiotics the bacteria will respond to, since antibiotic-resistant gonorrhea is a growing concern. But for routine screening and diagnosis, NAAT is the standard.
What the Sample Collection Looks Like
The type of sample depends on your anatomy and where the infection might be. For many people, the test is as simple as peeing in a cup. A first-void urine sample (the first stream when you urinate) is the standard collection for urethral infections, and you’ll typically be asked not to urinate for at least one hour before the test so the sample contains enough bacterial material.
For cervical or vaginal screening, a swab is used. In many clinics, you can collect a vaginal swab yourself by rotating the swab against the lower vaginal wall for 10 to 30 seconds. A provider-collected option involves a swab of the cervical canal. For men, a urethral swab is sometimes used instead of urine, though urine testing is more common because it’s less uncomfortable.
Gonorrhea can also infect the throat and rectum, so if you’ve had oral or anal sex, your provider may collect swabs from those sites separately. Throat and rectal infections often produce no symptoms at all, which is why site-specific testing matters. A urine test will not detect gonorrhea in the throat or rectum.
Why It’s Almost Always Paired With Chlamydia
If you see “GC/CT” on your lab order, that’s a combination test for gonorrhea (GC) and chlamydia (CT). These are the two most commonly reported notifiable infections in the U.S., they spread the same way, they often coexist in the same person, and they can both be detected from the same sample using the same NAAT platform. There’s no good reason to test for one without testing for the other, so labs run them together on a single specimen. Some newer tests also add screening for trichomoniasis, another common STI, from the same sample.
Who Should Get Tested
CDC screening guidelines recommend annual gonorrhea testing for all sexually active women under 25, and for women 25 and older who have risk factors like a new partner, multiple partners, or a partner with an STI. Pregnant women under 25 (or older with risk factors) should be tested early in pregnancy and again in the third trimester if at risk.
For men who have sex with men, annual screening at all sites of contact (urethra, rectum, throat) is recommended regardless of condom use. Those at higher risk, such as men with multiple partners, should be screened every 3 to 6 months. People living with HIV are recommended to screen at their first evaluation and at least annually after that.
For heterosexual men at low risk, routine screening isn’t specifically recommended, though testing makes sense after a potential exposure or if symptoms develop. Transgender and gender diverse individuals should follow screening recommendations based on their anatomy and sexual practices.
When to Test After Exposure
Gonorrhea has a short incubation period compared to many STIs. Most infections become detectable within 5 to 7 days after exposure, though some guidelines suggest waiting up to 2 weeks for the most reliable result. Testing too early after a potential exposure can produce a false negative simply because the bacteria hasn’t multiplied enough for the test to pick up. If you test negative but had a recent exposure, a follow-up test a couple of weeks later is reasonable.
After treatment for a confirmed infection, a retest at 3 months is recommended to check for reinfection, which is common.
Understanding Your Results
Results typically come back as “detected” (positive) or “not detected” (negative). NAAT tests are highly accurate, with the best sensitivity and specificity of any available gonorrhea test. A positive result means the genetic material of the gonorrhea bacterium was found in your sample. Because NAAT is so sensitive, false positives are rare but possible, and some providers may order a confirmatory test in low-risk populations.
A negative result means no gonorrhea DNA was detected. If you tested within the window period after a recent exposure, a negative result doesn’t completely rule out infection, and retesting may be warranted.
A positive GC test is treated with antibiotics, typically a single-dose injection. Sexual partners from the previous 60 days need to be notified and treated as well, even if they have no symptoms. Gonorrhea is curable, but untreated infections can lead to serious complications including pelvic inflammatory disease, infertility, and increased vulnerability to HIV.